| Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition G Soria, M Ofri-Shahak, I Haas, N Yaal-Hahoshen, L Leider-Trejo, ... BMC cancer 11, 1-20, 2011 | 321 | 2011 |
| The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer P Weitzenfeld, A Ben-Baruch Cancer letters 352 (1), 36-53, 2014 | 142 | 2014 |
| Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity I Ibarlucea-Benitez, P Weitzenfeld, P Smith, JV Ravetch Proceedings of the National Academy of Sciences 118 (26), e2107424118, 2021 | 104 | 2021 |
| Antibodies targeting sialyl Lewis A mediate tumor clearance through distinct effector pathways P Weitzenfeld, S Bournazos, JV Ravetch The Journal of clinical investigation 129 (9), 3952-3962, 2019 | 49 | 2019 |
| Epidermal growth factor and estrogen act by independent pathways to additively promote the release of the angiogenic chemokine CXCL8 by breast tumor cells K Haim, P Weitzenfeld, T Meshel, A Ben-Baruch Neoplasia 13 (3), 230-243, 2011 | 37 | 2011 |
| Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors P Weitzenfeld, O Kossover, C Körner, T Meshel, S Wiemann, D Seliktar, ... Journal of Leucocyte Biology 99 (6), 1009-1025, 2016 | 32 | 2016 |
| Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells P Weitzenfeld, T Meshel, A Ben-Baruch Oncotarget 7 (49), 81123, 2016 | 24 | 2016 |
| Progression of Luminal Breast Tumors Is Promoted by Ménage à Trois between the Inflammatory Cytokine TNFα and the Hormonal and Growth‐Supporting Arms of … P Weitzenfeld, N Meron, T Leibovich-Rivkin, T Meshel, A Ben-Baruch Mediators of Inflammation 2013 (1), 720536, 2013 | 21 | 2013 |
| The versatile world of inflammatory chemokines in cancer T Leibovich-Rivkin, Y Lebel-Haziv, S Lerrer, P Weitzenfeld, A Ben-Baruch The tumor immunoenvironment, 135-175, 2013 | 7 | 2013 |
| Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancer J Osorio, D Knorr, P Weitzenfeld, N Yao, M Baez, M DiLillo, J Rahman, ... | | 2024 |
Dror SeliktarTechnion, Biomedical Engineering在 bm.technion.ac.il 的电子邮件经过验证
